AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer - BioSpace
BioSpace reports on AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer in Science & Health.
Take A Coffee NEWS Staff··2 min read
BioSpace reported AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer. Take A Coffee NEWS is tracking the story on the Science & Health desk for readers following medicine, public health, research, climate, space, and science policy.
Source
Why it matters
The story belongs in this desk because it may affect readers tracking medicine, public health, research, climate, space, and science policy.